Nathsagar Bio-Genetics Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 13-12-2024
- Paid Up Capital ₹ 3.00 M
as on 13-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 9.00 M
as on 13-12-2024
- Satisfied Charges ₹ 9.80 M
as on 13-12-2024
- Revenue -0.25%
(FY 2022)
- Profit 78.69%
(FY 2022)
- Ebitda 58.87%
(FY 2022)
- Net Worth 15.12%
(FY 2022)
- Total Assets 56.82%
(FY 2022)
About Nathsagar Bio-Genetics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹9.80 M, as per Ministry of Corporate Affairs (MCA) records.
Manisha Satpute and Ashok Satpute serve as directors at the Company.
- CIN/LLPIN
U24233MH2013PTC241917
- Company No.
241917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nathsagar Bio-Genetics Private Limited offer?
Nathsagar Bio-Genetics Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Fungicides.
Who are the key members and board of directors at Nathsagar Bio-Genetics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Satpute  | Director | 16-Apr-2013 | Current |
| Manisha Satpute | Director | 16-Apr-2013 | Current |
Financial Performance of Nathsagar Bio-Genetics.
Nathsagar Bio-Genetics Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.25% decrease. The company also saw a substantial improvement in profitability, with a 78.69% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nathsagar Bio-Genetics?
In 2022, Nathsagar Bio-Genetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Dec 2021 | ₹9.00 M | Open |
Others Creation Date: 30 Nov 2020 | ₹3.00 M | Satisfied |
Others Creation Date: 07 Jun 2019 | ₹4.20 M | Satisfied |
How Many Employees Work at Nathsagar Bio-Genetics?
Nathsagar Bio-Genetics has a workforce of 1 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nathsagar Bio-Genetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nathsagar Bio-Genetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
